Recent Finacing
Recent Raise
Heidelberg Epignostix develops AI-driven bioinformatics algorithms that analyze DNA methylation patterns to classify brain tumor subtypes, support prognosis and therapy management via its Brain Tumor Classifier.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
